MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
February 14, 2005
Stephen D. Simpson
Apria Needs a Breather Home care provider will feel the pinch from lower Medicare reimbursement. Valuation is not out of line, but that doesn't necessarily make these shares a bargain. mark for My Articles similar articles
The Motley Fool
October 10, 2005
Stephen D. Simpson
Apria's One Selling Point The home health-care provider seems to really be in trouble as it shops itself to potential buyers. The possibility (probability?) of a sale does offer some protection here for aggressive investors. mark for My Articles similar articles
The Motley Fool
February 8, 2005
Stephen D. Simpson
Lincare Needs Some Air Will cuts in government reimbursement leave this home oxygen company short of breath? Investors who already own these shares might just want to hang on -- Lincare has been through this before mark for My Articles similar articles
The Motley Fool
April 19, 2005
Stephen D. Simpson
Taking the Air Out of Lincare Lincare has been through Medicare reimbursement cuts before. The big question is: How long before growth resumes? mark for My Articles similar articles
The Motley Fool
July 26, 2005
Stephen D. Simpson
Lincare Catching Its Breath Growth will be tough for now, but brighter days should lie ahead. Buying and/or holding the healthcare company's stock will be an exercise in patience and confidence in the management team. mark for My Articles similar articles
The Motley Fool
March 4, 2004
Philip Durell
Lincare Fighting for Air Lincare Holdings (Nasdaq: LNCR) knew it was coming and so did investors, but the severity of the new Medicare Bill has left them breathless! The November 2003 passing of the bill contained provisions that, if implemented, would severely cut revenues and net profit margins. mark for My Articles similar articles
The Motley Fool
February 2, 2011
Bryan Hinmon
Are Home Health Stocks Too Cheap? Home health agency stocks are cheap -- is now a time to buy? mark for My Articles similar articles
The Motley Fool
July 1, 2011
Luke Timmerman
Dendreon Sways Medicare to Pay for Prostate Cancer Drug The decision by Medicare is no surprise, but it does conclude a period of uncertainty about insurance reimbursement for its lone marketed product. mark for My Articles similar articles
Managed Care
September 2002
Medicare holds down physician pay Compensation increased at a comparatively small rate from 2000 to 2001 for both primary care physicians and specialists, according to the Medical Group Management Association. mark for My Articles similar articles